MANUEL
PRAGA TERENTE
Profesor emérito
Hospital Universitario La Fe
Valencia, EspañaHospital Universitario La Fe -ko ikertzaileekin lankidetzan egindako argitalpenak (13)
2018
-
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Kidney International, Vol. 93, Núm. 2, pp. 450-459
-
Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches
Nefrologia
-
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
Kidney International Reports, Vol. 3, Núm. 1, pp. 122-132
-
Podocytes are new cellular targets of haemoglobin-mediated renal damage
Journal of Pathology, Vol. 244, Núm. 3, pp. 296-310
2017
-
Eculizumab in secondary atypical haemolytic uraemic syndrome
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474
-
Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy
Kidney International, Vol. 92, Núm. 4, pp. 953-963
-
Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option
Nefrologia
2016
-
Altered underlying renal tubular function in patients with chronic hepatitis B receiving nucleos(t)ide analogs in a real-world setting the MENTE study
Journal of Clinical Gastroenterology, Vol. 50, Núm. 9, pp. 779-789
2015
-
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document
Nefrologia
-
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Kidney International, Vol. 88, Núm. 5, pp. 1153-1160
2014
-
Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 9, pp. 583-597
2012
-
Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria
Journal of the American Society of Nephrology, Vol. 23, Núm. 10, pp. 1753-1760
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32